NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

It would seem that Merck shares your deduction. Therefore, Merck got a jump on the competition by starting its Combo trial with the NWBO proxy drug (same drug different name) as stand in for current SOC protocols. After all if DC-Vax becomes SOC then all trials using current SOC as placebo will lose significance. Merck sees the writings in the Halls. Why is this so difficult for others? Oh maybe the oft repeated fallacy that the UCLA drug is different. Accepting this fallacy would force one to accept a completely illogical action of Merck to chose a Placebo arm which will never even have a chance to be SOC.